secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001193125-23-199180
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals launches proposed underwritten public offering of common stock
--------------------------------------------------------------------------------

- Company commenced proposed underwritten public offering of common stock under existing shelf registration.
- Terminated unused ATM prospectus; no shares were ever sold under that program.
- Sales Agreement with Jefferies LLC remains in effect, pending new prospectus.
- No details on size, pricing, or timing of the offering were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000119312523199180/0001193125-23-199180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000119312523199180/d473618d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-199180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer